Current Projects
The laboratory of Dr. Nina F. Schor is focused on the preclinical pharmacology of targeted therapies for neuroblastoma, a deadly childhood cancer. Of particular interest is the role of neurotrophin receptors and their interactors in resistance to chemotherapy of neuroblastoma cells and in redox regulation in the normal and neoplastic neural crest. The laboratory is currently funded by the William H. Eilinger Endowment of Golisano Children's Hospital of URMC and the Crosby Wilmot Fund for Pediatric Cancer Research.
- Role of Redundancy of Transcription Factors in Chemoresistance of Neuroblastoma
- Cell Type-Specific Conditional Knockout of p75NTR in the Mouse
- p75 Neurotrophin Receptor Signaling and Trafficking - a Role in Protection Against Oxidant Stress in Neurons
- Kidins220/ARMS: A Novel Regulator of Cell Differentiation in Neuroblastoma
- The Role of p75NTR and Its Signaling Pathways in Fenretinide-Induced Apoptosis in Neuroblastoma Cell
Contact Us
Schor Lab
University of Rochester Medical Center
Center for Neural Development and Disease
601 Elmwood Avenue
Box 645
Rochester, NY 14642
Phone: 585-273-1793
Fax: 585-276-1947
